Catalysts for $BIIB
16 tracked
Jul 30, 2026
earnings
BIOGEN INC. earnings
BIOGEN INC.
→
Jul 29, 2026
earnings
BIOGEN INC. earnings
BIOGEN INC.
→
Apr 30, 2026
phase 2 completion
Biogen Inc — DNL-151 (Phase II Trial Completion)
DNL-151
→
Apr 29, 2026
earnings
BIOGEN INC. earnings
BIOGEN INC.
→
Mar 27, 2026
approval
SPINRAZA (NUSINERSEN SODIUM) — FDA approval
BIOGEN INC.
→
Apr 10, 2024
approval
SPINRAZA (NUSINERSEN SODIUM) — FDA approval
BIOGEN INC.
→
Apr 10, 2024
approval
SPINRAZA (NUSINERSEN SODIUM) — FDA approval
BIOGEN INC.
→
Feb 17, 2023
approval
SPINRAZA (NUSINERSEN SODIUM) — FDA approval
BIOGEN INC.
→
Jun 16, 2020
approval
SPINRAZA (NUSINERSEN SODIUM) — FDA approval
BIOGEN INC.
→
Jun 17, 2019
approval
SPINRAZA (NUSINERSEN SODIUM) — FDA approval
BIOGEN INC.
→
Jun 17, 2019
approval
SPINRAZA (NUSINERSEN SODIUM) — FDA approval
BIOGEN INC.
→
Oct 10, 2018
approval
SPINRAZA (NUSINERSEN SODIUM) — FDA approval
BIOGEN INC.
→
May 14, 2018
approval
SPINRAZA (NUSINERSEN SODIUM) — FDA approval
BIOGEN INC.
→
May 14, 2018
approval
SPINRAZA (NUSINERSEN SODIUM) — FDA approval
BIOGEN INC.
→
Nov 21, 2017
approval
SPINRAZA (NUSINERSEN SODIUM) — FDA approval
BIOGEN INC.
→
Dec 23, 2016
approval
SPINRAZA (NUSINERSEN SODIUM) — FDA approval
BIOGEN INC.
→